Health / Medical Topics

    Mucoadhesive Paclitaxel Formulation

    An orally available, mucoadhesive lipid preparation consisting of paclitaxel, a compound extracted from the Pacific yew tree Taxus brevifolia, in a formulation that is comprised of a mixture of monoolein, tricarprylin, and Tween 80, with potential antineoplastic activity. Upon oral administration, DHP107 forms droplets and micelles in the intestine; these adhere to mucoepithelial cells in the gastrointestinal tract and are absorbed through lipid-based uptake mechanisms. Upon absorption, paclitaxel binds to and stabilizes tubulin molecules, which results in the inhibition of both microtubule depolymerization and cell division. This agent also induces apoptosis by both binding to and blocking the function of the apoptosis inhibitor protein B-cell Leukemia 2 (Bcl-2).The mucoadhesive paclitaxel formulation does not contain P-glycoprotein inhibitors, the solvent cremophor or any other toxic solvent. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A viscous, oral hydrogel rinse intended for the management of oral mucositis/stomatitis. Mucoadhesive oral wound rinse consists of purified water, glycerin, benzyl…
    Human MUCL1 wild-type allele is located in the vicinity of 12q and is approximately 4 kb in length. This allele, which encodes…
    This gene plays a role in cancer cell metastasis.
    A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular…
    A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools.
    A benign or low malignant potential cystic epithelial neoplasm composed of cells which contain intracytoplasmic mucin. It may arise from the ovary,…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact